Treatment of immunologically based disorders, specifically Crohn

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3455

Patent

active

050175750

ABSTRACT:
Means and methods for treating Crohn's disease, as an example of selectively influencing the immune systems of patients afflicted with intractable disorders and thereby abating or relieving the symptoms of such disorders, including many having an autoimmune abnormality or unbalance, such as an excessive concentration of killer T cells or an insufficient concentration of helper T cells or indeed both. A triazolo composition, such as a triazolobenzodiazepine, is administered to such a patient periodically in an amount effective to influence the immune system accordingly and to alleviate such symptoms, whereupon the dosage is gradually reduced to a maintenance level at which the symptoms do not recur but below which such recurrence is likely or certain.

REFERENCES:
patent: 3980789 (1976-09-01), Hester, Jr.
patent: 3980790 (1976-09-01), Hester, Jr.
patent: 4508726 (1985-04-01), Coleman

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of immunologically based disorders, specifically Crohn does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of immunologically based disorders, specifically Crohn, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of immunologically based disorders, specifically Crohn will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-238630

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.